Infinity Pharmaceuticals, Inc. (INFI) financial statements (2021 and earlier)

Company profile

Business Address 1100 MASSACHUSETTS AVENUE
CAMBRIDGE, MA 02138
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments3442595892245333
Cash and cash equivalents2922493574188307
Short-term investments6201023185725
Restricted cash and investments0   1  
Receivables    01 
Prepaid expense2211374
Other current assets0010512
Other undisclosed current assets      6
Total current assets:36456058102255345
Noncurrent Assets
Operating lease, right-of-use asset12
Property, plant and equipment2200232819
Long-term investments and receivables      1
Long-term investments      1
Restricted cash and investments00  122
Other noncurrent assets0001020
Other undisclosed noncurrent assets     23
Total noncurrent assets:3401243425
TOTAL ASSETS:39496059126289369
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities111086233431
Accounts payable32102106
Accrued liabilities8875212518
Employee-related liabilities      7
Debt   6   
Deferred revenue and credits  3524
Other undisclosed current liabilities    00(1)
Total current liabilities:1110812247055
Noncurrent Liabilities
Long-term debt and lease obligation12     
Operating lease, liability12
Liabilities, other than long-term debt0000010189
Deferred revenue and credits 010089
Other liabilities0000000
Other undisclosed noncurrent liabilities5030  192015
Total noncurrent liabilities:51320019120105
Total liabilities:624181243190160
Stockholders' equity
Stockholders' equity attributable to parent(23)852488299209
Common stock0000000
Additional paid in capital743733731715708694677
Accumulated other comprehensive income (loss)(0)0(0)(0)(0)00
Accumulated deficit(766)(726)(679)(668)(626)(596)(467)
Total stockholders' equity:(23)852488299209
TOTAL LIABILITIES AND EQUITY:39496059126289369

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues23226191090
Revenue, net619109 
Financial services revenue   0
Cost of revenue
(Cost of Goods and Services Sold)
     (23)(16)
Gross profit:232261986(16)
Operating expenses(40)(49)(34)(42)(162)(236)(173)
Other undisclosed operating income    11223181
Operating loss:(38)(46)(12)(36)(31)(127)(8)
Nonoperating income (expense)(2)(1)1(6)1(1)(9)
Investment income, nonoperating 1     
Other nonoperating income0 12200
Interest and debt expense(0)(3)(0)(1)(1)(1)(10)
Other undisclosed income from continuing operations before equity method investments, income taxes03011110
Loss from continuing operations before income taxes:(40)(47)(11)(43)(30)(128)(17)
Income tax expense (benefit) 0 1 (0)(0)
Net loss available to common stockholders, diluted:(40)(47)(11)(42)(30)(128)(17)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(40)(47)(11)(42)(30)(128)(17)
Comprehensive loss:(40)(47)(11)(42)(30)(128)(17)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)00(0)(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(41)(47)(11)(42)(30)(128)(17)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: